Clinical Trial Update: Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Cognitive Behavioral Therapy to improve adherence and reduce depression in Type 1 diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Type 1 Diabetes | Phase 2 | Status: COMPLETED